354 related articles for article (PubMed ID: 29481769)
1. Long noncoding RNA NKILA enhances the anti-cancer effects of baicalein in hepatocellular carcinoma via the regulation of NF-κB signaling.
Yu X; Tang W; Yang Y; Tang L; Dai R; Pu B; Feng C; Xia J
Chem Biol Interact; 2018 Apr; 285():48-58. PubMed ID: 29481769
[TBL] [Abstract][Full Text] [Related]
2. NKILA, a prognostic indicator, inhibits tumor metastasis by suppressing NF-κB/Slug mediated epithelial-mesenchymal transition in hepatocellular carcinoma.
Chen R; Cheng Q; Owusu-Ansah KG; Song G; Jiang D; Zhou L; Xu X; Wu J; Zheng S
Int J Biol Sci; 2020; 16(3):495-503. PubMed ID: 32015685
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA NKILA inhibits migration and invasion of tongue squamous cell carcinoma cells via suppressing epithelial-mesenchymal transition.
Huang W; Cui X; Chen J; Feng Y; Song E; Li J; Liu Y
Oncotarget; 2016 Sep; 7(38):62520-62532. PubMed ID: 27613832
[TBL] [Abstract][Full Text] [Related]
4. TGF-β-induced NKILA inhibits ESCC cell migration and invasion through NF-κB/MMP14 signaling.
Lu Z; Chen Z; Li Y; Wang J; Zhang Z; Che Y; Huang J; Sun S; Mao S; Lei Y; Gao Y; He J
J Mol Med (Berl); 2018 Apr; 96(3-4):301-313. PubMed ID: 29379981
[TBL] [Abstract][Full Text] [Related]
5. MiR-3663-3p participates in the anti-hepatocellular carcinoma proliferation activity of baicalein by targeting SH3GL1 and negatively regulating EGFR/ERK/NF-κB signaling.
Tian J; Li J; Bie B; Sun J; Mu Y; Shi M; Zhang S; Kong G; Li Z; Guo Y
Toxicol Appl Pharmacol; 2021 Jun; 420():115522. PubMed ID: 33838155
[TBL] [Abstract][Full Text] [Related]
6. NF-κB-Interacting Long Noncoding RNA Regulates HIV-1 Replication and Latency by Repressing NF-κB Signaling.
Wang H; Liu Y; Huan C; Yang J; Li Z; Zheng B; Wang Y; Zhang W
J Virol; 2020 Aug; 94(17):. PubMed ID: 32581100
[TBL] [Abstract][Full Text] [Related]
7. Baicalein inhibits cervical cancer progression via downregulating long noncoding RNA BDLNR and its downstream PI3K/Akt pathway.
Yu X; Yang Y; Li Y; Cao Y; Tang L; Chen F; Xia J
Int J Biochem Cell Biol; 2018 Jan; 94():107-118. PubMed ID: 29175387
[TBL] [Abstract][Full Text] [Related]
8. LncRNA NKILA suppresses TGF-β-induced epithelial-mesenchymal transition by blocking NF-κB signaling in breast cancer.
Wu W; Chen F; Cui X; Yang L; Chen J; Zhao J; Huang D; Liu J; Yang L; Zeng J; Zeng Z; Pan Y; Su F; Cai J; Ying Z; Zhao Q; Song E; Su S
Int J Cancer; 2018 Nov; 143(9):2213-2224. PubMed ID: 29761481
[TBL] [Abstract][Full Text] [Related]
9. LncRNA NKILA inhibits invasion and migration of osteosarcoma cells via NF-κB/Snail signaling pathway.
Zhang GD; Li Y; Liao GJ; Qiu HW
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4118-4125. PubMed ID: 31173281
[TBL] [Abstract][Full Text] [Related]
10. LncRNA NKILA upregulation mediates oxygen glucose deprivation/re-oxygenation-induced neuronal cell death by inhibiting NF-κB signaling.
Wang M; Jiang YM; Xia LY; Wang Y; Li WY; Jin T
Biochem Biophys Res Commun; 2018 Sep; 503(4):2524-2530. PubMed ID: 30007440
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA NKILA inhibited angiogenesis of breast cancer through NF-κB/IL-6 signaling pathway.
Luo LH; Rao L; Luo LF; Chen K; Ran RZ; Liu XL
Microvasc Res; 2020 May; 129():103968. PubMed ID: 31862380
[TBL] [Abstract][Full Text] [Related]
12. NKILA inhibits NF-κB signaling and suppresses tumor metastasis.
Ke S; Li RC; Meng FK; Fang MH
Aging (Albany NY); 2018 Jan; 10(1):56-71. PubMed ID: 29348395
[TBL] [Abstract][Full Text] [Related]
13. Baicalein: A review of its anti-cancer effects and mechanisms in Hepatocellular Carcinoma.
Bie B; Sun J; Guo Y; Li J; Jiang W; Yang J; Huang C; Li Z
Biomed Pharmacother; 2017 Sep; 93():1285-1291. PubMed ID: 28747003
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA NKILA inhibits migration and invasion of non-small cell lung cancer via NF-κB/Snail pathway.
Lu Z; Li Y; Wang J; Che Y; Sun S; Huang J; Chen Z; He J
J Exp Clin Cancer Res; 2017 Apr; 36(1):54. PubMed ID: 28412955
[TBL] [Abstract][Full Text] [Related]
15. The reduced lncRNA NKILA inhibited proliferation and promoted apoptosis of chondrocytes via miR-145/SP1/NF-κB signaling in human osteoarthritis.
Xue H; Yu P; Wang WZ; Niu YY; Li X
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):535-548. PubMed ID: 32016955
[TBL] [Abstract][Full Text] [Related]
16. A cytoplasmic NF-κB interacting long noncoding RNA blocks IκB phosphorylation and suppresses breast cancer metastasis.
Liu B; Sun L; Liu Q; Gong C; Yao Y; Lv X; Lin L; Yao H; Su F; Li D; Zeng M; Song E
Cancer Cell; 2015 Mar; 27(3):370-81. PubMed ID: 25759022
[TBL] [Abstract][Full Text] [Related]
17. Long Non-Coding RNA NKILA Reduces Oral Squamous Cell Carcinoma Development Through the NF-KappaB Signaling Pathway.
Hu D; Zhong T; Dai Q
Technol Cancer Res Treat; 2020; 19():1533033820960747. PubMed ID: 33143574
[TBL] [Abstract][Full Text] [Related]
18. LncRNA NKILA inhibits HBV replication by repressing NF-κB signalling activation.
Zhang X; Li Y; Huan C; Hou Y; Liu R; Shi H; Zhang P; Zheng B; Wang Y; Wang H; Zhang W
Virol Sin; 2024 Feb; 39(1):44-55. PubMed ID: 37832719
[TBL] [Abstract][Full Text] [Related]
19. Preferential inhibition of hepatocellular carcinoma by the flavonoid Baicalein through blocking MEK-ERK signaling.
Liang RR; Zhang S; Qi JA; Wang ZD; Li J; Liu PJ; Huang C; Le XF; Yang J; Li ZF
Int J Oncol; 2012 Sep; 41(3):969-78. PubMed ID: 22684543
[TBL] [Abstract][Full Text] [Related]
20. Sorafenib pretreatment enhances radiotherapy through targeting MEK/ERK/NF-κB pathway in human hepatocellular carcinoma-bearing mouse model.
Chen JC; Chuang HY; Hsu FT; Chen YC; Chien YC; Hwang JJ
Oncotarget; 2016 Dec; 7(51):85450-85463. PubMed ID: 27863427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]